Login / Signup

The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.

Federico BardazziDiego AbbenanteFederica FilippiLidia SacchelliCamilla Loi
Published in: Dermatologic therapy (2021)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • ejection fraction
  • healthcare
  • newly diagnosed
  • sars cov
  • prognostic factors
  • patient reported outcomes
  • pain management
  • chronic pain
  • respiratory syndrome coronavirus